Publication

Feifel D, et al. Single Intranasal Administration of the Psychedelic Mebufotenin for Treatment-Resistant Depression. JAMA, 2026

DOI 10.1001/jama.2026.18380

Фаза 2b (NCT05870540), двойное слепое, 193 взрослых с резистентной депрессией, 38 центров. MADRS к 29-му дню: −11,1 против −5,5 (разница −5,3; 95% ДИ −8,9…−1,8). Ответ 34–35% против 12%. Спонсор Beckley Psytech.

News about this publication

Also in the catalogue

Scales

Identifiers

DOI
10.1001/jama.2026.18380

Original sources

Details

Journal
JAMA
Year
2026

A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.